Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniele Cattaneo

Showing results (1-10 of 149) with videos related to

Pageof 15
Sort By:
Frontiers in Immunology|December 6, 2021
Immune Dysregulation and Infectious Complications in MPN Patients Treated With JAK InhibitorsDaniele Cattaneo, Alessandra Iurlo
Anti-Cancer Drugs|May 9, 2025
Reply to: Association between nilotinib-induced hyperbilirubinemia and UGT1A1 polymorphisms in a chronic myeloid leukemia patientDaniele Cattaneo, Alessandra Iurlo
Clinical Medicine Insights. Blood Disorders|June 6, 2017
Treatment of Myelofibrosis: Old and New StrategiesAlessandra Iurlo, Daniele Cattaneo
Blood Reviews|September 24, 2022
Biologic therapies for hypereosinophilic disorders: From tyrosine kinase inhibitors to monoclonal antibodies. Towards an increasingly customized management?Alessandra Iurlo, Daniele Cattaneo
Expert Review of Hematology|October 8, 2019
Hypereosinophilic syndromes in the precision medicine era: clinical, molecular aspects and therapeutic approaches (targeted therapies)Alessandra Iurlo, Daniele Cattaneo, Umberto Gianelli
Current Treatment Options in Oncology|May 1, 2020
Management of Myelofibrosis: from Diagnosis to New Target TherapiesAlessandra Iurlo, Daniele Cattaneo, Cristina Bucelli
International Journal of Molecular Sciences|April 25, 2019
Blast Transformation in Myeloproliferative Neoplasms: Risk Factors, Biological Findings, and Targeted Therapeutic OptionsAlessandra Iurlo, Daniele Cattaneo, Umberto Gianelli
Current Treatment Options in Oncology|May 17, 2023
Essential Thrombocythemia in Adolescents and Young Adults: Clinical Aspects, Treatment Options and Unmet Medical NeedsAlessandra Iurlo, Cristina Bucelli, Daniele Cattaneo
Hemasphere|December 11, 2025
Atypical chronic myeloid leukemia: From diagnosis to molecular features and therapeutic optionsAlessandra Iurlo, Daniele Cattaneo, Umberto Gianelli, et al.
Journal of Clinical Medicine|February 4, 2021
Dose Optimization of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A New Therapeutic ChallengeAlessandra Iurlo, Daniele Cattaneo, Cristina Bucelli, et al.
Pageof 15

Showing results (1-10 of 149) with videos related to

Sort By:
Pageof 15
Frontiers in Immunology|December 6, 2021
Immune Dysregulation and Infectious Complications in MPN Patients Treated With JAK InhibitorsDaniele Cattaneo, Alessandra Iurlo
Anti-Cancer Drugs|May 9, 2025
Reply to: Association between nilotinib-induced hyperbilirubinemia and UGT1A1 polymorphisms in a chronic myeloid leukemia patientDaniele Cattaneo, Alessandra Iurlo
Clinical Medicine Insights. Blood Disorders|June 6, 2017
Treatment of Myelofibrosis: Old and New StrategiesAlessandra Iurlo, Daniele Cattaneo
Blood Reviews|September 24, 2022
Biologic therapies for hypereosinophilic disorders: From tyrosine kinase inhibitors to monoclonal antibodies. Towards an increasingly customized management?Alessandra Iurlo, Daniele Cattaneo
Expert Review of Hematology|October 8, 2019
Hypereosinophilic syndromes in the precision medicine era: clinical, molecular aspects and therapeutic approaches (targeted therapies)Alessandra Iurlo, Daniele Cattaneo, Umberto Gianelli
Current Treatment Options in Oncology|May 1, 2020
Management of Myelofibrosis: from Diagnosis to New Target TherapiesAlessandra Iurlo, Daniele Cattaneo, Cristina Bucelli
International Journal of Molecular Sciences|April 25, 2019
Blast Transformation in Myeloproliferative Neoplasms: Risk Factors, Biological Findings, and Targeted Therapeutic OptionsAlessandra Iurlo, Daniele Cattaneo, Umberto Gianelli
Current Treatment Options in Oncology|May 17, 2023
Essential Thrombocythemia in Adolescents and Young Adults: Clinical Aspects, Treatment Options and Unmet Medical NeedsAlessandra Iurlo, Cristina Bucelli, Daniele Cattaneo
Hemasphere|December 11, 2025
Atypical chronic myeloid leukemia: From diagnosis to molecular features and therapeutic optionsAlessandra Iurlo, Daniele Cattaneo, Umberto Gianelli, et al.
Journal of Clinical Medicine|February 4, 2021
Dose Optimization of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A New Therapeutic ChallengeAlessandra Iurlo, Daniele Cattaneo, Cristina Bucelli, et al.
Pageof 15